Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperaldosteronism associated with liver metastases

K J Pandya, R Whitehead, J Crowley

    JAMA
    |July 11, 1980
    PubMed
    Summary

    Patients with liver metastases and fluid retention show higher aldosterone levels. This suggests spironolactone may help manage edema in advanced liver disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Urgent Virtual Care: Impact on GP, Emergency, and Scheduled Care Pathways.

    Irish medical journal·2026
    Same author

    Breeding for sustainability: Development of an index to reduce greenhouse gas in dairy cattle.

    Animal : an international journal of animal bioscience·2025
    Same author

    Implementing Faecal Immunochemical Testing in Primary Care.

    Irish medical journal·2024
    Same author

    A Video Analysis of Helmet Area Injuries and Helmet Type Worn in Hurling and Camogie Over 2 Seasons.

    Irish medical journal·2024
    Same author

    Training generative adversarial networks for optical property mapping using synthetic image data.

    Biomedical optics express·2022
    Same author

    Improvements in Clinical Outcomes in Children with Cystic Fibrosis aged Six and 16 years.

    Irish medical journal·2022

    Area of Science:

    • Endocrinology and Oncology
    • Hepatic Metabolism and Fluid Balance

    Background:

    • Advanced metastatic liver disease can lead to complex physiological changes.
    • Fluid retention (edema and ascites) is a common complication in these patients.
    • The role of aldosterone in liver metastases-associated edema requires clarification.

    Purpose of the Study:

    • To investigate plasma aldosterone levels in patients with liver metastases.
    • To correlate aldosterone levels with the presence of edema and ascites.
    • To assess the relationship between hepatic dysfunction and aldosterone levels.

    Main Methods:

    • Plasma aldosterone levels were measured in 50 patients with confirmed liver metastases.
    • Patients were screened for electrolyte abnormalities and pre-existing conditions.
    • Aldosterone levels were compared between edematous and non-edematous groups.

    Main Results:

    • Significantly elevated plasma aldosterone levels were observed in patients with edema and/or ascites.
    • Patients with fluid retention exhibited markers of substantial hepatic dysfunction (low albumin, high bilirubin/alkaline phosphatase).
    • Non-edematous patients had lower plasma aldosterone levels.

    Conclusions:

    • Elevated aldosterone is associated with edema in patients with liver metastases.
    • Hepatic dysfunction is a key factor in this edematous state.
    • Spironolactone, an aldosterone inhibitor, is a rational therapeutic option for managing edema in advanced liver disease.

    Related Experiment Videos